University of Southern California
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).
University of Southern California: 617 sponsored US clinical trials, 97 recruiting.
University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
617 total, page 11 of 13
Arm Rehabilitation Study After Stroke
NCT00871715
Avastin for PDR (Proliferative Diabetic Retinopathy)
NCT01270542
Gestational Diabetes Follow Up Study
NCT00998595
A Trial of Meal Replacement at a Community Diabetes Clinic Serving a Low Socioeconomic Hispanic Population
NCT01729117
Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer
NCT02237612
Ankle Sprains and Corticospinal Excitability
NCT00847769
Mobile Device Biomonitoring to Prevent and Treat Obesity in Underserved Youth
NCT02017223
Pressure Ulcer Prevention Study in SCI
NCT01999816
Time Interval for Endoscopic Variceal Ligation
NCT01291277
Herbal Therapy for Treatment of Recurrent Prostate Cancer
NCT00669656
Oral Carnitine for Cramps in Pregnancy
NCT00516516
Green Tea in Breast Cancer Patients
NCT00949923
Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families
NCT00986011
Doxycycline Effects on Inflammation in Cystic Fibrosis
NCT01323101
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
NCT00667147
Oral NRX 194204 in Patients With Refractory Malignancies
NCT00630760
Supplements for Controlling Resistance to Insulin
NCT00699413
Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
NCT00599170
The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
NCT00605072
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
NCT00598247
Theta-burst Transcranial Magnetic Stimulation
NCT00878787
BION Active Seating for Pressure Ulcer Prevention
NCT00628602
BION Treatment of Dysphagia After Radical Head-Neck Surgery
NCT00628485
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
NCT00556907
Food, Adolescence, Mood, and Exercise
NCT02015377
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
NCT00972439
Strength Training and Nutrition Development for African American Youth
NCT01441323
Validation of the Stayhealthy BC1 Body Comp Analyzer
NCT01209923
Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy
NCT00473161
Translational Obesity Research
NCT00787709
Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug
NCT00450671
Guided Imagery Intervention for Obese Latino Adolescents
NCT01895595
Use of EMG to Assess Clinical Hypertonia
NCT00472914
Multifaceted Depression and Cardiovascular Program
NCT02069912
Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair
NCT00520416
Synchronized Intermittent Mandatory Ventilation (SIMV) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) In Preterm Infants With Respiratory Distress
NCT00486850
Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men
NCT00365794
A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
NCT00183963
Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer
NCT00336141
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
NCT01338792
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
NCT00457366
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
NCT00323011
Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy
NCT02550119
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
NCT00573924
Developing a Self-Management Program for People With Depression and Chronic Medical Illness
NCT00523029
Quantification of Upper Extremity Hypertonia
NCT00285870
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
NCT00352326
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
NCT02587663
Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings
NCT00260169
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
NCT00282906
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 83 |
| Phase 2 | 90 |
| Phase 3 | 9 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the University of Southern California pipeline
97 recruiting of 617 indexed (16% open); 361 completed (59%).
Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Southern California: open-pipeline peers nationwide
Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 617 trials (± recruiting share)
- Baylor College of Medicine · 616 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Youngstown State University · 16% recruiting · 19 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this University of Southern California page
617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.
- 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.